top of page


Accelerating Start-ups by Design

Accelerating Startups by Design is Ontario Genomics' annual synthetic biology pitch competition wherein start-ups utilizing synthetic biology get the opportunity to pitch their companies in front of a panel of all-stat investors. The winning pitch will take home the prize of $10,000 CAD courtesy of IndieBio.




Claudia Krywiak.png
Claudia Krywiak
Colin Kelleher.png
Colin Kelleher
Kelleher Group
Eileen MCMAHON.png
Eileen McMahon
Torys LLP 
Qasim Mohammad.png
Qasim Mohammad Wittington Ventures 
Stephen Chambers.png
Stephen Chambers
IndieBio New York 


Bio-Brick Logo.png
Genuine Taste Logo.png
Hilo Bio Logo.jpg
MetaCycler Logo.png
Synakis Logo Blue.png

Process Description – hold these dates!

  1. May 26, 2023 at noon - Submission of 4-page written application

  2. May 31, 2023 - Interview

  3. June 15, 2023 - Conference Pitch Competition

Check out the winners from our last annual Canada SynBio Conference Pitch Competition!


Contact Michael Dorrington, Manager, Strategic Partnerships, for more information!  


  • Startups must be based in Canada

  • Incorporated on or after January 1, 2020 (pre-incorporation companies are eligible but must incorporate if they’re successful and before receiving any funds)  

  • Raised less than $500,000 in funding 

  • Products or services being developed must be a synthetic biology/engineering biology technology or enabled by these technologies in any relevant sector (eg. Bioproducts, health, food, agriculture, natural resources, etc.)

  • Companies must have an IP strategy 

  • Companies must demonstrate access to lab resources as required

Canada’s population is highly diverse, and effective and authentic diversity and inclusion strategies are essential for Canadian organizations to thrive and achieve their goals. We encourage applications from diverse teams and all equity-deserving groups.


  • The funding is offered as a grant, without any ownership stake in the company or any intellectual property being taken by Ontario Genomics or its partners 

  • Periodic reporting on the impact of the funding received will be required 

  • Detailed terms will be provided in the funding agreement  

bottom of page